GoodRx shares rose 1.5% in premarket trading Tuesday after the healthcare company said it will offer a 30-day supply of oral ...

Qsymia’s manufacturer also released postmarketing data showing the oral therapy for weight loss was associated with ...

GoodRx has officially entered the weight loss drug market by offering an exclusive discount on the once-daily oral medication Qsymia.

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today that QSYMIA® (phentermine and topiramate extended-release ...

VIVUS announced today that the U.S. Food and Drug Administration has removed the requirement for a cardiovascular outcome trial for its weight-management medication QSYMIA (phentermine and ...

Investing.com -- GoodRx shares rose 1.5% in premarket trading Tuesday after the healthcare company said it will offer a 30-day supply of oral weight management drug Qsymia for $149. The stock lost ...